Posted in | News | Industrial Robotics

Novus Robotics’ Subsidiary Delivers Aluminum Components Processing System for Ford Truck

D&R Technology Inc, wholly owned subsidiary of Novus Robotics Inc, (NRBT) an applied-robotics and automation company is pleased to announce that it has successfully delivered one and in process of manufacturing second aluminum components processing system for new Ford-150 truck.

Already a market leader in delivering automotive tube processing equipment, the company sees the gradual conversion of automotive body to aluminum as a "game changer" for downstream aluminum use, with a growth rate higher than any other end market for the rest of this decade.

Building on the strength of experience, company was able to gain access to new developing market by offering a broad array of newly adopted technologies and modules. The versatility of the modules, as well as its ease of integration, allowed it to quickly make inroads in one of the most demanding market in the world alongside a top, pioneering automotive suppliers.

"Development of aluminum stretching and processing technologies is a very important step for D&R, as it confirms the value of our team and allows us to enter one of the most exiting markets today. I believe several automotive platforms will move toward partial or full aluminum body in the coming years - the Ford-150 is merely "the tip of the iceberg," mentioned Drasko Karanovic, President and CEO of D&R Technology Inc. "Furthermore, introduction of new technologies into our portfolio will enhance our performance and competitive advantages," adds Mr. Dino Paolucci, CEO of Novus Robotics Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.